Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02309099 · ClinicalTrials.gov registry record · NA

Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02309099 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02309099, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The goal of this project is to determine whether subjects who have undergone labyrinthectomy or a translabyrinthine surgical approach as the treatment for vestibular schwannoma or Meniere's disease benefit from cochlear implantation on speech perception and localization tasks. If the auditory nerve is able to transmit this signal effectively, then these two populations may be able to utilize the combination of electric (in the affected ear) and acoustic (in the non-affected ear) information for improved speech perception in noise and localization as reportedly experienced in other unilateral sensorineural hearing loss populations.

Interventions

  • DEVICE Cochlear Implant

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-11
Est. Completion 2017-11-08
Phase NA

What the Registry Record Tells You About NCT02309099

The ClinicalTrials.gov registry entry for NCT02309099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cochlear Implant is the first listed.

NCT02309099 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02309099 about?

NCT02309099 is a clinical study titled "Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach". The goal of this project is to determine whether subjects who have undergone labyrinthectomy or a translabyrinthine surgical approach as the treatment for vestibular schwannoma or Meniere's disease benefit from cochlear implantation on speech perception and localization tasks. If the auditory nerve...

What is the current status of trial NCT02309099?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-11. Estimated completion is 2017-11-08.

What interventions are being tested in trial NCT02309099?

The interventions under investigation include: Cochlear Implant (DEVICE).

Who is sponsoring clinical trial NCT02309099?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.